Rb+ flux through hERG channels affects the potency of channel blocking drugs: correlation with data obtained using a high-throughput Rb+ efflux assay.
about
Computer-based prediction of the drug proarrhythmic effect: problems, issues, known and suspected challengesA new homogeneous high-throughput screening assay for profiling compound activity on the human ether-a-go-go-related gene channel.Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-à-go-go related gene potassium channels.Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay.A highly selective mitochondria-targeting fluorescent K(+) sensor.An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing riskCardiac slices as a predictive tool for arrhythmogenic potential of drugs and chemicals.Screening technologies for ion channel drug discovery.Advances in functional assays for high-throughput screening of ion channels targets.Predicting drug-induced QT prolongation and torsades de pointes: a review of preclinical endpoint measures.Targeting cardiac potassium channels for state-of-the-art drug discovery.Development of recombinant cell line co-expressing mutated Nav1.5, Kir2.1, and hERG for the safety assay of drug candidates.In Vitro and In Silico Risk Assessment in Acquired Long QT Syndrome: The Devil Is in the Details.
P2860
Q26861453-52FD374B-82A6-40C1-A469-E96A36FF0A40Q33479407-00068C13-ED4D-4980-B795-475CCD825687Q33772055-158D7161-6DF5-4979-9853-584B694E2627Q35883599-E4D5B1F5-C559-4403-BE3B-BEF7EE63B41EQ36749715-FCB14D7E-3FD5-46EB-83D5-81CB1BC6E0C9Q37689202-4AA0DBB4-1CAA-4B81-A709-215BFCF50705Q37808482-E4DDABE3-4253-49F3-9461-BF1F6119C96CQ37855923-95332E6D-A80C-4FA9-B936-7D6909228B59Q38028660-DF9428D3-D1FD-46FF-9F9F-CA37239055D0Q38112652-85CC8212-A17A-4C7B-866E-2570BE235ADBQ38268573-6E627453-5BCE-4501-B2C8-04D8930C7A0EQ39365157-5F934348-B03E-44FE-9966-1625776C81D1Q47095257-73513F49-830B-4894-8978-7B033FFF0D16
P2860
Rb+ flux through hERG channels affects the potency of channel blocking drugs: correlation with data obtained using a high-throughput Rb+ efflux assay.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Rb+ flux through hERG channels ...... h-throughput Rb+ efflux assay.
@ast
Rb+ flux through hERG channels ...... h-throughput Rb+ efflux assay.
@en
type
label
Rb+ flux through hERG channels ...... h-throughput Rb+ efflux assay.
@ast
Rb+ flux through hERG channels ...... h-throughput Rb+ efflux assay.
@en
prefLabel
Rb+ flux through hERG channels ...... h-throughput Rb+ efflux assay.
@ast
Rb+ flux through hERG channels ...... h-throughput Rb+ efflux assay.
@en
P2093
P356
P1476
Rb+ flux through hERG channels ...... h-throughput Rb+ efflux assay.
@en
P2093
David Fedida
J Christian Hesketh
Saman Rezazadeh
P304
P356
10.1177/1087057104264798
P577
2004-10-01T00:00:00Z